220 related articles for article (PubMed ID: 26768127)
1. Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.
Sakthi S; Palaniyandi K; Gupta UD; Gupta P; Narayanan S
Vaccine; 2016 Feb; 34(6):735-43. PubMed ID: 26768127
[TBL] [Abstract][Full Text] [Related]
2. The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs.
Martin C; Williams A; Hernandez-Pando R; Cardona PJ; Gormley E; Bordat Y; Soto CY; Clark SO; Hatch GJ; Aguilar D; Ausina V; Gicquel B
Vaccine; 2006 Apr; 24(17):3408-19. PubMed ID: 16564606
[TBL] [Abstract][Full Text] [Related]
3. Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis.
Sander P; Clark S; Petrera A; Vilaplana C; Meuli M; Selchow P; Zelmer A; Mohanan D; Andreu N; Rayner E; Dal Molin M; Bancroft GJ; Johansen P; Cardona PJ; Williams A; Böttger EC
Vaccine; 2015 Mar; 33(11):1353-9. PubMed ID: 25657094
[TBL] [Abstract][Full Text] [Related]
4. Secretory phosphatases deficient mutant of Mycobacterium tuberculosis imparts protection at the primary site of infection in guinea pigs.
Chauhan P; Reddy PV; Singh R; Jaisinghani N; Gandotra S; Tyagi AK
PLoS One; 2013; 8(10):e77930. PubMed ID: 24205032
[TBL] [Abstract][Full Text] [Related]
5. The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.
Brandt L; Skeiky YA; Alderson MR; Lobet Y; Dalemans W; Turner OC; Basaraba RJ; Izzo AA; Lasco TM; Chapman PL; Reed SG; Orme IM
Infect Immun; 2004 Nov; 72(11):6622-32. PubMed ID: 15501795
[TBL] [Abstract][Full Text] [Related]
6. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
de Lisle GW; Wards BJ; Buddle BM; Collins DM
Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
[TBL] [Abstract][Full Text] [Related]
8. Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.
Marcus SA; Steinberg H; Talaat AM
Vaccine; 2015 Oct; 33(42):5633-5639. PubMed ID: 26363381
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protection induced by Mycobacterium tuberculosis mce-2 and mce-3 mutants in a Balb/c mouse model of progressive pulmonary tuberculosis.
Aguilar LD; Infante E; Bianco MV; Cataldi A; Bigi F; Pando RH
Vaccine; 2006 Mar; 24(13):2333-42. PubMed ID: 16388878
[TBL] [Abstract][Full Text] [Related]
10. bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs.
Kar R; Nangpal P; Mathur S; Singh S; Tyagi AK
PLoS One; 2017; 12(6):e0179513. PubMed ID: 28658275
[TBL] [Abstract][Full Text] [Related]
11. The lpqS knockout mutant of Mycobacterium tuberculosis is attenuated in macrophages.
Sakthi S; Narayanan S
Microbiol Res; 2013 Aug; 168(7):407-14. PubMed ID: 23562345
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis sigE mutant ST28 used as a vaccine induces protective immunity in the guinea pig model.
Troudt J; Creissen E; Izzo L; Bielefeldt-Ohmann H; Casonato S; Manganelli R; Izzo AA
Tuberculosis (Edinb); 2017 Sep; 106():99-105. PubMed ID: 28802412
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of recombinant (Ag85A) BCG Tokyo with Ag85A peptide boosting against Mycobacterium tuberculosis-infected guinea pigs in comparison with that of DNA vaccine encoding Ag85A.
Sugawara I; Udagawa T; Taniyama T
Tuberculosis (Edinb); 2007 Mar; 87(2):94-101. PubMed ID: 16815096
[TBL] [Abstract][Full Text] [Related]
14. Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
Clark S; Lanni F; Marinova D; Rayner E; Martin C; Williams A
J Infect Dis; 2017 Sep; 216(5):525-533. PubMed ID: 28329234
[TBL] [Abstract][Full Text] [Related]
15. Hyper-attenuated MTBVAC erp mutant protects against tuberculosis in mice.
Solans L; Uranga S; Aguilo N; Arnal C; Gomez AB; Monzon M; Badiola JJ; Gicquel B; Martin C
Vaccine; 2014 Sep; 32(40):5192-7. PubMed ID: 25066740
[TBL] [Abstract][Full Text] [Related]
16. Protective efficacy of Mycobacterium indicus pranii against tuberculosis and underlying local lung immune responses in guinea pig model.
Gupta A; Ahmad FJ; Ahmad F; Gupta UD; Natarajan M; Katoch VM; Bhaskar S
Vaccine; 2012 Sep; 30(43):6198-209. PubMed ID: 22871353
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium indicus pranii as a booster vaccine enhances BCG induced immunity and confers higher protection in animal models of tuberculosis.
Saqib M; Khatri R; Singh B; Gupta A; Kumar A; Bhaskar S
Tuberculosis (Edinb); 2016 Dec; 101():164-173. PubMed ID: 27865389
[TBL] [Abstract][Full Text] [Related]
18. [Protective efficacy of BCG Tokyo 172 in the guinea pig model of pulmonary tuberculosis].
Yamamoto T; Phalen S; Uchida K; Umemori K; Nojima Y; Horiuchi Y; Goto Y; McMurray DN; Yamamoto S
Kekkaku; 2000 May; 75(5):379-88. PubMed ID: 10853313
[TBL] [Abstract][Full Text] [Related]
19. Differential proteomics approach to identify putative protective antigens of Mycobacterium tuberculosis presented during early stages of macrophage infection and their evaluation as DNA vaccines.
Sharma S; Rajmani RS; Kumar A; Bhaskar A; Singh A; Manivel V; Tyagi AK; Rao KV
Indian J Exp Biol; 2015 Jul; 53(7):429-39. PubMed ID: 26245027
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.
Obregón-Henao A; Shanley C; Bianco MV; Cataldi AA; Basaraba RJ; Orme IM; Bigi F
Vaccine; 2011 Jun; 29(26):4302-7. PubMed ID: 21515327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]